Valsartan and Acinetobacter infection - a phase IV clinical study of FDA data
Summary:
Acinetobacter infection is reported as a side effect among people who take Valsartan (valsartan), especially for people who are female, 40-49 old, have been taking the drug for 2 - 5 years also take Phoslo, and have Chronic renal failure.
The phase IV clinical study analyzes which people have Acinetobacter infection when taking Valsartan. It is created by eHealthMe based on reports of 62,763 people who have side effects when taking Valsartan from the FDA, and is updated regularly.
What is Valsartan?
Valsartan has active ingredients of valsartan. It is often used in high blood pressure. eHealthMe is studying from 63,805 Valsartan users. Check the latest studies of Valsartan.
What is Acinetobacter infection?
Acinetobacter infection (infection by group of bacteria commonly found in soil and water) is found to be associated with 136 drugs and 414 conditions by eHealthMe. Check the latest studies of Acinetobacter infection.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
62,763 people reported to have side effects when taking Valsartan.
Among them, 11 people (0.02%) have Acinetobacter infection.

Among these 11 people:
How long have people been on Valsartan when they have Acinetobacter infection? *
- < 1 month: 0.0 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 100 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Acinetobacter infection when taking Valsartan? *
- female: 90.91 %
- male: 9.09 %
What is the age of people who have Acinetobacter infection when taking Valsartan? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 54.55 %
- 50-59: 9.09 %
- 60+: 36.36 %
What are other drugs people take besides Valsartan? *
- Cartia Xt: 6 people, 54.55%
- Sodium Bicarbonate: 6 people, 54.55%
- Phoslo: 6 people, 54.55%
- Lidocaine: 2 people, 18.18%
- Cranberry: 2 people, 18.18%
- Eliquis: 2 people, 18.18%
- Epinephrine: 2 people, 18.18%
- Esomeprazole Magnesium: 2 people, 18.18%
- Hydrochlorothiazide: 2 people, 18.18%
- Incruse Ellipta: 2 people, 18.18%
What are other side effects people have besides Acinetobacter infection? *
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 8 people, 72.73%
- Leukocytosis (increased white blood cells): 6 people, 54.55%
- Haemosiderosis (general increase in tissue iron stores without associated tissue damage): 6 people, 54.55%
- Thrombocytopenia (decrease of platelets in blood): 6 people, 54.55%
- Lymphopenia (an abnormally low level of lymphocytes in the blood): 6 people, 54.55%
- Haemoglobin Decreased: 6 people, 54.55%
- Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 6 people, 54.55%
- Neutralising Antibodies Positive: 6 people, 54.55%
- Plasmacytosis (presence of lots of plasma cells in bone or other tissues): 6 people, 54.55%
- Aplasia Pure Red Cell (type of anaemia affecting the precursors to red blood cells but not to white blood cells): 6 people, 54.55%
What are the existing conditions these people have? *
- Chronic Renal Failure (kidney failure): 6 people, 54.55%
- Immunodeficiency Common Variable: 2 people, 18.18%
- Tumor Pain: 1 person, 9.09%
- Respiratory Tract Infection: 1 person, 9.09%
- Oedema Peripheral (superficial swelling): 1 person, 9.09%
- Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 1 person, 9.09%
- Lung Cancer - Non-Small Cell (lung cancer): 1 person, 9.09%
- Insomnia (sleeplessness): 1 person, 9.09%
- Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 9.09%
- Cough: 1 person, 9.09%
* Approximation only. Some reports may have incomplete information.
Do you take Valsartan and have Acinetobacter infection?
- Check whether Acinetobacter infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Valsartan:
- Valsartan (63,805 reports)
Acinetobacter infection treatments and more:
- Acinetobacter infection (1,717 reports)
How severe was Acinetobacter infection and when was it recovered:
Expand to all the drugs that have ingredients of valsartan:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Valsartan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Acinetobacter infection:
- Acinetobacter infection (136 drugs)
Browse all the conditions that are associated with Acinetobacter infection:
- Acinetobacter infection (414 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on valsartan (the active ingredients of Valsartan) and Valsartan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Profen cause Cervical Cyst? - 6 seconds ago
- Aranesp and Sedation for Men aged 60+ - 10 seconds ago
- Myositis and drugs of ingredients of budesonide - 17 seconds ago
- Veramyst and Azithromycin drug interactions for women aged 60+ - 21 seconds ago
- How effective is Requip for Agitation Aggravated? - 27 seconds ago
- Could Lidocaine Hydrochloride cause Rash Macular? - 41 seconds ago
- Could Januvia cause Hepatorenal Syndrome? - 48 seconds ago
- Paclitaxel and Hemiparesis for Women aged 60+ - 54 seconds ago
- Garlic and Colace drug interactions for women aged 60+ - 55 seconds ago
- Could Slow-K cause Agitation? - 59 seconds ago